SCHEMBL31542073

SCHEMBL31542073

COc1ccc(-n2c(Cc3ccc(C(N)=O)c(O)c3)nc3ccccc3c2=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
MEN1 O00255 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
KMT2A Q03164 1/20 0.58
PDE10A Q9Y233 10/20 0.56
GAA P10253 1/20 0.53
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
NPSR1 Q6W5P4 1/20 0.51
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542084 0.81 ALDH1A1 (0.78) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL31542069 0.79 ALDH1A1 (0.75) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL451250 0.77 ALDH1A1 (0.76) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL7014792 0.76 ALDH1A1 (0.74) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL4580818 0.76 ALDH1A1 (0.64) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL409520 0.75 MEN1 (0.80) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL453594 0.75 ALDH1A1 (0.76) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL4393425 0.75 ALDH1A1 (0.76) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL15154005 0.73 PDE10A (0.77) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL7016256 0.72 ALDH1A1 (0.64) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed